Description
CV70 is a 1,8-Diaza-anthracene-tetrone compound that exhibits anticancer activity in vitro, inhibiting the activation of JNK and ERK5.
CV70 is a 1,8-Diaza-anthracene-tetrone compound that exhibits anticancer activity in vitro, inhibiting the activation of JNK and ERK5.
| Purity | ≥70% |
|---|---|
| Formula | C16H14N2O4 |
| Formula Wt. | 298.29 |
| Appearance | Red Powder |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet | |
| Brochures |
Pipaón C, Gutierrez P, Montero JC, et al. Mitogen-activated protein kinase routes as targets in the action of diaza-anthracene compounds with a potent growth-inhibitory effect on cancer cells. Mol Cancer Ther. 2002 Aug;1(10):811-9. PMID: 12492114.
Hydroxycinnamic aicd, verbascoside metabolite, ...
Peptide, derivative of AT II, involved in vasoc...
Fermentation impurity
BHA derivative; potential Ca2+ ATPase inhibitor...
Active compound found in turmeric; MST1 activat...
Imidzoline derivative; MDM2 inhibitor.
Polyphenolic compound present in black tea.
Nucleoside antibiotic mixture; GlcNAc phosphotr...
ALK inhibitor.
Synthetic glucocorticoid
Taxane synthesis intermediate.
Triterpenoid
Endogenous peptide involved in vascular contrac...
Focal adhesion kinase (FAK) inhibitor.
Sesquiterpene lactone derived from Artemesia; m...
Neuraminidase inhibitor.
Melatonin analog; MT1/2 agonist.
Semi-synthetic peptide, melanocortin analog; MC...
VEGFR, PDGFR, c-Kit inhibitor.
Diterpene found in Rosmarinus.